SEL1L a multifaceted protein playing a role in tumor progression
暂无分享,去创建一个
S. Ménard | A. Scarpa | I. Biunno | S. Ferrero | R. Orlandi | M. Cattaneo | S. Pupa | C. Canton | L. Biagiotti | Massimo Barberis
[1] A. Pappo,et al. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. , 2006, American journal of clinical pathology.
[2] I. Biunno,et al. SEL1L expression in prostatic intraepithelial neoplasia and adenocarcinoma: an immunohistochemical study , 2006, Histopathology.
[3] T. E. Hinds. Diseases , 2021, Modeling Biological Systems.
[4] D. Delia,et al. SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactions. , 2005, Neoplasia.
[5] Aaron S. Gajadhar,et al. A High Throughput Screen to Identify Substrates for the Ubiquitin Ligase Rsp5* , 2005, Journal of Biological Chemistry.
[6] S. Kamauchi,et al. Gene expression in response to endoplasmic reticulum stress in Arabidopsis thaliana , 2005, The FEBS journal.
[7] S. Ménard,et al. Protein profile changes in the human breast cancer cell line MCF‐7 in response to SEL1L gene induction , 2005, Proteomics.
[8] Mary K. Lewinski,et al. Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription , 2005, Journal of Virology.
[9] N. Gaiano,et al. Notch signaling in the mammalian central nervous system: insights from mouse mutants , 2005, Nature Neuroscience.
[10] Ulrich Wagner,et al. Genome‐wide analysis of the unfolded protein response in fibroblasts from congenital disorders of glycosylation type‐I patients , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] P. Richardson,et al. Proteasome inhibition as a novel therapeutic target in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Stuart K. Calderwood,et al. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.
[13] J. Califano,et al. Impact of Chromosome 14 q Loss on Survival in Primary Head and Neck Squamous Cell Carcinoma , 2005 .
[14] M. Stefani. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. , 2004, Biochimica et biophysica acta.
[15] P. Hu,et al. Critical Role of Endogenous Akt/IAPs and MEK1/ERK Pathways in Counteracting Endoplasmic Reticulum Stress-induced Cell Death* , 2004, Journal of Biological Chemistry.
[16] Kathryn L. Lipson,et al. High ER stress in beta-cells stimulates intracellular degradation of misfolded insulin. , 2004, Biochemical and biophysical research communications.
[17] Patrick Maisonneuve,et al. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.
[18] D. Antonello,et al. Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy. , 2004, Mutation research.
[19] K. Politi,et al. Notch in mammary gland development and breast cancer. , 2004, Seminars in cancer biology.
[20] S. Bosari,et al. SEL1L and Squamous Cell Carcinoma of the Esophagus , 2004, Clinical Cancer Research.
[21] I. Biunno,et al. RNA-mediated interference indicates that SEL1L plays a role in pancreatic beta-cell growth. , 2004, DNA and cell biology.
[22] K. Chin,et al. In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.
[23] L. Whitesell,et al. Altered Hsp90 function in cancer: a unique therapeutic opportunity. , 2004, Molecular cancer therapeutics.
[24] M. Grütter,et al. The crystal structure of Helicobacter cysteine-rich protein C at 2.0 A resolution: similar peptide-binding sites in TPR and SEL1-like repeat proteins. , 2004, Journal of molecular biology.
[25] H. Moch,et al. [Pediatric renal cell carcinoma]. , 2004, Der Pathologe.
[26] H. Moch,et al. Nierenzellkarzinome bei jungen Patienten , 2004, Der Pathologe.
[27] Edward M. Rubin,et al. Megabase deletions of gene deserts result in viable mice , 2004, Nature.
[28] K. Hoang-Xuan,et al. Loss of 14q Chromosome in Oligodendroglial and Astrocytic Tumors , 2004, Journal of Neuro-Oncology.
[29] Salvatore Pece,et al. Endocytosis and cancer. , 2004, Current opinion in cell biology.
[30] A. Koromilas,et al. Control of Tumor Suppressor p53 Function by Endoplasmic Reticulum Stress , 2004, Cell cycle.
[31] Nicola J. Rinaldi,et al. Control of Pancreas and Liver Gene Expression by HNF Transcription Factors , 2004, Science.
[32] I. Biunno,et al. Identification of a region within SEL1L protein required for tumour growth inhibition. , 2004, Gene.
[33] E. Stavridi,et al. p53 and stress in the ER. , 2004, Genes & development.
[34] V. Chau,et al. Human HRD1 Is an E3 Ubiquitin Ligase Involved in Degradation of Proteins from the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.
[35] N. Blin,et al. Promoter selection for the cytosine deaminase suicide gene constructs in gastric cancer , 2004, European journal of gastroenterology & hepatology.
[36] S. Wagner,et al. Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma. , 2004, Cancer letters.
[37] Y. Nomura,et al. ER signaling in unfolded protein response. , 2003, Life sciences.
[38] H. Edlund,et al. Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.
[39] Somasekar Seshagiri,et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. , 2003, Genome research.
[40] B. Osborne,et al. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents , 2003, Oncogene.
[41] S. Ménard,et al. SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivo , 2003, Oncogene.
[42] N. Blin,et al. Assessing optimal promoter activity for constructs in gastrointestinal gene therapy. , 2003, Anticancer research.
[43] Ruedi Aebersold,et al. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.
[44] D. Wolf,et al. For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin–proteasome connection , 2003, The EMBO journal.
[45] Jeffrey L. Wrana,et al. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.
[46] Larry Kedes,et al. HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.
[47] Thomas E. Willnow,et al. Functional interaction of megalin with the megalinbinding protein (MegBP), a novel tetratrico peptide repeat-containing adaptor molecule , 2003, Journal of Cell Science.
[48] J. Wrana,et al. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. , 2003, Nature cell biology.
[49] R. Kaufman. Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.
[50] D. Ron,et al. Translational control in the endoplasmic reticulum stress response. , 2002, The Journal of clinical investigation.
[51] G. Sherbet,et al. Notch signal transduction is not regulated by SEL1L in leukaemia and lymphoma cells in culture. , 2002, Anticancer research.
[52] M. Kressel,et al. Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15. , 2002, Human molecular genetics.
[53] M. Kiraly,et al. A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response , 2002, The Journal of cell biology.
[54] E. Dees,et al. The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer , 2002, Breast Cancer Research.
[55] R. Hampton. ER-associated degradation in protein quality control and cellular regulation. , 2002, Current opinion in cell biology.
[56] H. Ng,et al. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours , 2002, British Journal of Cancer.
[57] M. Campiglio,et al. Production of a monoclonal antibody directed against the recombinant SEL1L protein. , 2002 .
[58] S. Ying,et al. Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin 1 , 2002, Experimental biology and medicine.
[59] S. Ménard,et al. SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro. , 2002, Cancer research.
[60] I. Rogozin,et al. Cross-species conservation of SEL1L, a human pancreas-specific expressing gene. , 2002, Omics : a journal of integrative biology.
[61] S. Ménard,et al. SEL 1 L Expression Decreases Breast Tumor Cell Aggressiveness in Vivo and in Vitro 1 , 2002 .
[62] S. Ménard,et al. Allelic polymorphisms in the transcriptional regulatory region of human SEL1L. , 2001, Mutation research.
[63] F. Pociot,et al. Complete mutation scanning of the human SEL 1L gene: a candidate gene for type 1 diabetes , 2001, Acta Diabetologica.
[64] J. Buchner,et al. Hsp90: Chaperoning signal transduction , 2001, Journal of cellular physiology.
[65] F. Pociot,et al. No evidence for SEL1L as a candidate gene for IDDM11‐conferred susceptibility , 2001, Diabetes/metabolism research and reviews.
[66] Serge Lemay,et al. The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin* , 2001, The Journal of Biological Chemistry.
[67] M. Asashima,et al. Activin A induces expression of rat Sel-1l mRNA, a negative regulator of notch signaling, in rat salivary gland-derived epithelial cells. , 2001, Biochemical and biophysical research communications.
[68] Jonathan Boyd,et al. The hairpin structure of the 6F11F22F2 fragment from human fibronectin enhances gelatin binding , 2001, The EMBO journal.
[69] T. Yanagawa,et al. SEL1L microsatellite polymorphism in Japanese patients with autoimmune thyroid diseases. , 2001, Thyroid : official journal of the American Thyroid Association.
[70] I. Rogozin,et al. Cloning and functional analysis of SEL1L promoter region, a pancreas-specific gene. , 2001, DNA and cell biology.
[71] R. Lothe,et al. Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas. , 2001, Scandinavian journal of gastroenterology.
[72] C. Ponting. Proteins of the endoplasmic-reticulum-associated degradation pathway: domain detection and function prediction. , 2000, The Biochemical journal.
[73] O. Volpert,et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[74] M. Sudol,et al. The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] S. Ménard,et al. The Expression of Sel1L and Tan-1 in Normal and Neoplastic Cells , 2000, The International journal of biological markers.
[76] P. Dear,et al. SEL1L, the human homolog of C. elegans sel-1: refined physical mapping, gene structure and identification of polymorphic markers , 2000, Human Genetics.
[77] B. Osborne,et al. Arbiter of differentiation and death: Notch signaling meets apoptosis , 1999, Journal of cellular physiology.
[78] G. Blatch,et al. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[79] A. Tanigami,et al. Complete cDNA sequence and genomic organization of a human pancreas-specific gene homologous to Caenorhabditis elegans sel-1 , 1999, Journal of Human Genetics.
[80] G. Kovacs,et al. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. , 1999, The American journal of surgical pathology.
[81] S. Artavanis-Tsakonas,et al. Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .
[82] A. Bernstein,et al. Cloning and characterization of Sel-1l, a murine homolog of the C. elegans sel-1 gene , 1998, Mechanisms of Development.
[83] F. Gago,et al. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy , 1998, International journal of cancer.
[84] I. Greenwald,et al. LIN-12/Notch signaling: lessons from worms and flies. , 1998, Genes & development.
[85] I. Fentiman,et al. Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients. , 1998, European Journal of Cancer.
[86] D. Barford,et al. The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR‐mediated protein–protein interactions , 1998, The EMBO journal.
[87] V. Sgaramella,et al. Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas. , 1997, Genomics.
[88] S. Artavanis-Tsakonas,et al. Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2 , 1997, Molecular and cellular biology.
[89] W. Richards,et al. The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene , 1997, Oncogene.
[90] W. Poon,et al. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. , 1997, Human pathology.
[91] S. Goodman,et al. Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.
[92] D. Gallahan,et al. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4) , 1997, Oncogene.
[93] W. Richards,et al. Isolation and characterization of liver epithelial cell lines from wild-type and mutant TgN737Rpw mice. , 1997, The American journal of pathology.
[94] J. Califano,et al. Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[95] I. Greenwald,et al. Structure, function, and expression of SEL-1, a negative regulator of LIN-12 and GLP-1 in C. elegans. , 1997, Development.
[96] D. Slamon,et al. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b , 1997, Oncogene.
[97] Suna Wang,et al. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. , 1996, Oncogene.
[98] J. Rine,et al. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. , 1996, Molecular biology of the cell.
[99] Kathleen R. Cho,et al. DPC4 gene in various tumor types. , 1996, Cancer research.
[100] I. Greenwald,et al. The Caenorhabditis elegans sel-1 gene, a negative regulator of lin-12 and glp-1, encodes a predicted extracellular protein. , 1996, Genetics.
[101] J. Sklar,et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.
[102] R. Coombes,et al. Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells. , 1996, Cancer research.
[103] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.